Advanced NanoBiomed Research
Scope & Guideline
Exploring the Future of Nanobiotechnology
Introduction
Aims and Scopes
- Nanomaterials for Drug Delivery:
Research related to the design and application of nanomaterials as drug delivery systems, enhancing the efficacy and targeting of therapeutic agents. - Tissue Engineering and Regenerative Medicine:
Studies aimed at developing scaffolds and biomaterials for tissue regeneration, focusing on the interaction between cells and engineered materials. - Biosensing and Diagnostics:
Innovations in biosensing technologies utilizing nanomaterials for the detection of biomarkers, pathogens, and diseases. - Cancer Therapy and Immunotherapy:
Research on nanotechnology applications in cancer treatment, including targeted therapy, immunotherapy, and theranostics. - Biocompatible Materials:
Development of biocompatible materials that can interact safely with biological systems for various therapeutic applications. - Microfluidics and Organ-on-a-Chip Technologies:
Application of microfluidic systems for biological assays, drug testing, and modeling of human organs for biomedical research.
Trending and Emerging
- Smart and Responsive Nanocarriers:
Increased research on stimuli-responsive nanocarriers for targeted and controlled drug delivery, which allows for enhanced therapeutic effects and reduced side effects. - Biomimetic Materials:
A growing focus on materials that mimic biological systems, enhancing compatibility and functionality in biomedical applications. - Nanotechnology in Regenerative Medicine:
Emerging studies on the application of nanotechnology for regenerative medicine, including stem cell therapy and tissue repair mechanisms. - Machine Learning and AI in Nanomedicine:
The integration of machine learning and artificial intelligence to predict the behavior of nanomaterials and improve drug design processes is gaining traction. - Multi-Modal Therapeutic Approaches:
Research is increasingly focusing on combination therapies that integrate multiple modalities, including photothermal, photodynamic, and immunotherapy, to enhance cancer treatment outcomes.
Declining or Waning
- Traditional Drug Formulations:
Research focusing on conventional drug formulations and delivery methods seems to be less prevalent, with a shift towards more innovative nanotechnology-based approaches. - Basic Nanomaterial Properties:
Studies that primarily investigate the fundamental properties of nanomaterials without clear biomedical applications are becoming less common. - In Vivo Animal Studies:
There is a noticeable decrease in the number of publications emphasizing in vivo animal studies, as the focus shifts towards more advanced in vitro models and organ-on-a-chip technologies.
Similar Journals
Biomaterials Science
Transforming ideas into impactful biomaterials for tomorrow's challenges.Biomaterials Science is a premier journal published by the Royal Society of Chemistry that serves as a leading platform for researchers and professionals in the fields of Biomedical Engineering and Materials Science. With an impressive impact factor bolstered by its Q1 quartile ranking in both disciplines, this journal has positioned itself at the forefront of cutting-edge research, showcasing innovative materials and applications that drive advancements in healthcare and technology. Since its inception in 2013, Biomaterials Science has been committed to disseminating high-quality, peer-reviewed articles that promote scientific knowledge and collaboration among academia and industry. With a global readership and a focus on open access, researchers are encouraged to share their findings to facilitate the development of transformative biomaterials and their applications. Join a vibrant community of scholars as we explore the future of biomaterials through this esteemed publication, enhancing both scientific inquiry and practical application.
APL Bioengineering
Unleashing the Potential of Bioengineering InterdisciplinarityAPL Bioengineering is a premier open-access journal published by AIP Publishing, dedicated to advancing the field of bioengineering and its interdisciplinary applications. Established in 2017, this journal serves as a vital platform for researchers, professionals, and students interested in the critical intersections of bioengineering, biomaterials, biomedical engineering, and biophysics. With an impressive impact factor and consistent rankings in the Q1 category across multiple domains, including biochemistry and materials science, APL Bioengineering has positioned itself among the top journals in its field. The journal aims to publish innovative original research, comprehensive reviews, and insightful case studies that further the understanding and application of bioengineering principles. Since its inception, APL Bioengineering has fostered a community of thought leaders, providing open access to ensure broad dissemination of knowledge and advancements that underpin the future of biomedical innovation.
BME Frontiers
Bridging Research and Real-World Healthcare SolutionsBME Frontiers, published by the American Association for the Advancement of Science, is an innovative open-access journal dedicated to the burgeoning field of Biomedical Engineering. Since its establishment in 2020, this journal has aimed to bridge the gap between cutting-edge research and practical application, promoting advancements in biomedical technologies, medical devices, and healthcare solutions. Boasting impressive rankings within Scopus—64th among 398 in Medicine (miscellaneous) and 81st among 303 in Biomedical Engineering—BME Frontiers stands out as a significant contributor to scholarly communication, offering rich insights for researchers, professionals, and students alike. With consistent publication projected through 2024, the journal serves as an essential platform for disseminating high-quality research that can drive innovation and inspire new approaches in the healthcare sector.
Materials Science & Engineering C-Materials for Biological Applications
Innovating the intersection of materials science and biology.Materials Science & Engineering C-Materials for Biological Applications is a premier journal published by ELSEVIER, dedicated to advancing the field of biomaterials through interdisciplinary research. With a robust ISSN of 0928-4931, this journal has made its mark in the realms of Chemical Engineering and Materials Science, achieving impressive Scopus rankings within its categories, namely Rank #16/151 in Bioengineering (89th percentile) and Rank #13/112 in Biomaterials (88th percentile). Although the journal's coverage in Scopus has been discontinued since 2021, it remains a critical resource for researchers, professionals, and students eager to explore innovative materials and their applications in biological contexts. The journal’s open access policy enhances its accessibility, fostering a global exchange of knowledge and inspiring future advancements in the field of materials science.
Biomaterials Advances
Transforming Ideas into Applications in Biomaterials ScienceBiomaterials Advances is a premier journal published by Elsevier, dedicated to the rapidly evolving field of biomaterials. Established in the United Kingdom, this open-access journal aims to disseminate high-quality, peer-reviewed research that explores innovative biomaterial designs and their applications in bioengineering and biomedical engineering. With an impressive 2023 impact factor reflected in its Q1 rankings across multiple categories—including Bioengineering, Biomaterials, and Biomedical Engineering—Biomaterials Advances stands out as a critical platform for scholars and practitioners faced with advancing technologies and methodologies in the realm of materials science. Covering a broad range of topics, from biocompatibility to tissue engineering, this journal provides an inclusive forum for researchers seeking to contribute to the field. Its Scopus rankings further affirm its position as a leading resource, with notable standings in Biomedical Engineering (Rank #13), Biomaterials (Rank #8), and Bioengineering (Rank #11), all within the top percentiles. Researchers and students alike are encouraged to contribute and engage with the latest findings and innovations in biomaterials through this valuable publication.
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
Pioneering research in biocompatible materials for medical innovation.JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A, published by WILEY, is a leading journal in the field of biomaterials and biomedical engineering, showcasing cutting-edge research that bridges the gap between material science and healthcare applications. With a robust 2023 impact factor reflecting its high-quality contributions, this journal is classified in the Q2 quartile for Biomaterials, Biomedical Engineering, and Ceramics and Composites, while achieving an impressive Q1 ranking in Metals and Alloys. The journal caters to a diverse readership, including researchers, professionals, and students, aiming to facilitate innovation and advancements in biocompatible materials and their applications in medical devices and tissue engineering. Access options for readers are available, ensuring the latest studies and findings are readily accessible to all stakeholders in this dynamic field. As it progresses towards its 2024 target, the JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A continues to be an essential resource for anyone involved in the development and application of biomedical materials.
International Journal of Biomaterials
Driving innovation in biomedical engineering through accessible research.The International Journal of Biomaterials, published by HINDAWI LTD, is a premier platform for disseminating groundbreaking research in the fields of biomaterials and biomedical engineering. With an Open Access approach since 2009, this journal provides unhindered access to innovative studies and applications aimed at advancing medical technologies and improving patient outcomes. Notably ranked in the Q3 category for both Biomaterials and Biomedical Engineering in 2023, it serves as an essential resource for researchers, practitioners, and students alike. The journal's Scopus rankings, including a 49th percentile in Biomedical Engineering and a 40th percentile in Biomaterials, further underscore its growing prominence in the academic community. With contributions spanning from 2011 to 2024, the journal seeks to foster collaborative research and promote developments that enhance the understanding and application of biomaterials in healthcare.
Nanotechnology and Precision Engineering
Unlocking the potential of nanoscale advancements.Nanotechnology and Precision Engineering is a leading open access journal published by AIP Publishing, dedicated to advancing the fields of nanotechnology and precision engineering. Established in 2006, the journal has become a vital resource for researchers, professionals, and students, reflecting the latest advancements in Electrical and Electronic Engineering, Industrial and Manufacturing Engineering, Instrumentation, Mechanical Engineering, and Nanoscience. With an impressive variety of quartile rankings in Scopus—notably Q1 in several key engineering domains—the journal provides a robust platform for disseminating groundbreaking research. Noteworthy aspects include its open access format introduced in 2018, ensuring that high-quality research is freely accessible to a global audience. By maintaining a commitment to excellence and collaboration, Nanotechnology and Precision Engineering plays a crucial role in shaping the future of technology and innovation.
Annual Review of Biomedical Engineering
Unveiling Cutting-Edge Research in Healthcare TechnologyAnnual Review of Biomedical Engineering, published by Annual Reviews, stands as a leading academic journal dedicated to the rapidly evolving field of biomedical engineering. With an impressive impact factor that reflects its high citation rates and rigorous peer-review process, this journal offers critical insights by synthesizing cutting-edge advancements and applications in both biomedical engineering and miscellaneous medicine. The journal, which is available in both print (ISSN: 1523-9829) and electronic formats (E-ISSN: 1545-4274), serves as an essential resource for researchers, professionals, and students aiming to stay abreast of significant developments and emerging trends. As of 2023, it is recognized in the top tier (Q1) for both Biomedical Engineering and Medicine, showcasing its esteemed position within the academic community, reflected in its high Scopus rankings. Spanning from 1999 to 2024, the Annual Review of Biomedical Engineering continues to catalyze interdisciplinary collaboration and innovation at the intersection of engineering and healthcare.
BIOMEDICAL MICRODEVICES
Unleashing Potential in Biomedical MicrodevicesBIOMEDICAL MICRODEVICES is a leading journal published by Springer that focuses on the innovative field of microdevices within biomedical engineering. With an ISSN of 1387-2176 and an E-ISSN of 1572-8781, BIOMEDICAL MICRODEVICES offers a prestigious platform for researchers to disseminate their findings from 1998 to 2024, demonstrating a long-standing commitment to advancing knowledge in this critical area. The journal is recognized for its significant contributions, boasting a Q2 ranking in Biomedical Engineering and Nanoscience and Nanotechnology, and a Q3 rank in Molecular Biology. Renowned for its rigorous peer-review process, it is positioned within the top 30% of its field according to Scopus rankings, making it a valuable resource for researchers and practitioners alike. Though it operates under a subscription model, the emphasis on quality and relevance within its scope ensures that BIOMEDICAL MICRODEVICES remains a vital source of cutting-edge research that bridges engineering and biological systems, fostering innovation and collaboration in the pursuit of novel health solutions.